Concepedia

Publication | Open Access

<i>In Vitro</i> and <i>In Vivo</i> Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells

322

Citations

42

References

2011

Year

Abstract

Our preclinical study supports clinical evaluation of MLN9708, alone or in combination, as a potential MM therapy.

References

YearCitations

Page 1